Home) Article Archive) Subjects) Product Development/Formulation Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.

 

		General Articles Considerations in selecting a contract manufacturing organization CROs and OINDP development Getting started with CFD MDI propellants Nasal spray regulatory approval Outsourcing inhalation product development Selecting a dose counter Selecting an MDI can US Payers and OINDPS What is the future of HFA pMDIs? A patent-based perspective Technical Articles In vitro particle deposition in the nasal cavity A "smart" move: The development of electronic devices for nasal aerosols Abbreviated Impactor Measurement (AIM) and Efficient Data Analysis (EDA) Concepts: A partnership for the assurance of Oral Inhaled Product (OIP) quality Addressing the patient-device use interface: Development and laboratory validation of a facemask with anatomically-responsive face models Addressing the patient-device use interface: Why patient-friendly features are important Aerosolized adhesive coating of cascade impactor plates An approach to particle size stability Application of organotypic in vitro human cell culture models for research and development of inhalation pharmaceutical formulations targeting the proximal airways Atomic force microscopy (AFM): A quantitative tool for excipient screening of pMDI formulations Choosing between capsules and blisters Contributions of mechanical stress on the “frustrated” thermal response of griseofulvin Critical evaluation of the revised and new USP chapters for aerosols: <601> and <5> [Pharm Forum 2011; 37(4)] Delivery of inhaled bronchodilators by breath-actuated jet nebulizer: The potential for improved adherence with clinical guidelines Developing OINDPs using Quality by Design Development of inhalable dry-powder formulations for low water-soluble products using spray-dried engineered particles DPI development: Understanding the technical challenges Effective inhalation treatment for acute fungal infections Elastomers in orally inhaled and nasal drug products, Part I: Elastomer selection and qualification Elastomers in orally inhaled and nasal drug products, Part II: Control strategies Evaluating the Alberta Throat: An innovation to support the acquisition of more clinically applicable aerosol aerodynamic particle size distribution (APSD) data in oral inhaled product (OIP) development Evolution of nasal aerosol products for pain management Excipients in DPI Formulations Formulation and characterization of nasal sprays From actuation to deposition: Particle sizing techniques for characterizing nasal drug delivery systems Gene–environment interactions in asthma: Lessons for the development of new drugs for asthma High pressure homogenization as an alternative methodology to micronization for obtaining effective inhalation particles Impact of capsule selection on formulation stability in dry powder inhalers (DPIs) Innovation in analytical tools: More signal and less noise in particle size testing of inhaled products LC-MSD as a platform for inhalation product development Micromolding as a potential manufacturing route for dry powder formulations Opportunities for capsule-based DPIs in emerging markets Parameters to consider in software for respiratory drug and device testing Particle design for respiratory drug delivery: Challenges and processing options Particle engineering for inhalation formulation and delivery of biotherapeutics Pharmacoscintigraphy Principles of nebulizer technology Product development: Case study of an inhaled biologic Redundancy Based Development (RBD) for a dry powder inhaler Significant restriction of the delivered dose uniformity criteria in the revised USP Chapter for Aerosols <601> The effect of shaking on solution MDIs The role of intelligent sorbents in respiratory drug delivery devices The use of cyclodextrins in formulations for lung delivery Thixotropic sprays: Popular with patients, challenging for developers Using MDIs to deliver pDNA Webinars Development of Idealized Throat Replicas for Inhaler Testing, 7/11